676
Views
19
CrossRef citations to date
0
Altmetric
Reviews

Emerging drugs for acne

, &
Pages 649-659 | Published online: 22 Sep 2009

Bibliography

  • Kraning KK, Odland GF. Prevalence, morbidity and cost of dermatologic diseases. J Invest Dermatol 1979;73(Suppl):395-401
  • James WD. Clinical practice: acne. N Engl J Med 2005;352(14):1463-72
  • Harper JC, Fulton J. Acne vulgaris. eMedicine Dermatology 2008. Available from: http://emedicine.medscape.com/article/1069804-overview. [Accessed on 22 April 2009]
  • Tan JK. Psychosocial impact of acne vulgaris: evaluating the evidence. Skin Therapy Lett 2004;9(7):1-3,9
  • Management of acne: summary, evidence report/technology assessment. No. 17. Rockville, Md.: Agency for Healthcare Research and Quality, March 2001. (AHRQ publication no. 01-E018)
  • Nestor MS. The use of photodynamic therapy for treatment of acne vulgaris. Dermatol Clin 2007;25(1):47-57
  • Burkhart CN, Burkhart CG. Microbiologic principle of biofilms as a major factor in pathogenesis of acne. Int J Dermatol 2003;42:925-7
  • Kaminer MS, Gilchrest BA. The many faces of acne. J Am Acad Dermatol 1995;32(5 Pt 3):S6-14
  • Tan JKL. Current measures for the evaluation of acne severity. Expert Rev Dermatol 2008;3(5):595-603
  • Degitz K, Ochsendorf F. Pharmacotherapy of acne. Expert Opin Pharmacother 2008;9(6):955-97
  • Waller JM, Dreher F, Behnam S, ‘Keratolytic’ properties of benzoyl peroxide and retinoic acid resemble salicylic acid in man. Skin Pharmacol Physiol 2006;19(5):283-9
  • Nacht S, Gans EH, McGinley KJ, Kligman AM. Comparative activity of benzoyl peroxide and hexachlorophene. In vivo studies against Propionibacterium acnes in humans. Arch Dermatol 1983;119(7):577-9
  • Weinberg JM. The utility of benzoyl peroxide in hydrophase base (Brevoxyl) in the treatment of acne vulgaris. J Drugs Dermatol 2006;5(4):344-9
  • Dreno B. Topical antibacterial therapy for acne vulgaris. Drugs 2004;64(21):2389-97
  • Dreno B, Bettoli V, Ochsendorf F, European recommendations on the use of oral antibiotics for acne. Eur J Dermatol 2004;14(6):391-9
  • Margolis DJ, Bowe WP, Hoffstad O, Berlin JA. Antibiotic treatment of acne may be associated with upper respiratory tract infections. Arch Dermatol 2005;141(9):1132-6
  • Ochsendorf F. Systemic antibiotic therapy of acne vulgaris. J Dtsch Dermatol Ges 2006;4(10):828-41
  • Lim DS, Murphy GM. High-level ultraviolet A photoprotection is needed to prevent doxycycline phototoxicity: lessons learned in East Timor. Br J Dermatol 2003;149:213-4
  • Haider A, Shaw JC. Treatment of acne vulgaris. JAMA 2004;292(6):726-35
  • Tan AW, Tan HH. Acne vulgaris: a review of antibiotic therapy. Expert Opin Pharmacother 2005;6(3):409-18
  • Koren G, Avner M, Shear N. Generic isotretinoin: a new risk for unborn children. CMAJ 2004;170:1567-8
  • Koulianos GT. Treatment of acne with oral contraceptives: criteria for pill selection. Cutis 2000;66(4):281-6
  • Shaw JC. Low-dose adjunctive spironolactone in the treatment of acne in women: a retrospective analysis of 85 consecutively treated patients. J Am Acad Dermatol 2000;43(3):498-502
  • Burkhart CN, Burkhart CG. Antibiotic-resistant Propionibacteria acnes may not be the major issue clinically or microbiologically in acne. Br J of Dermatol 2003;148(2):365-6
  • Ross JI, Snelling AM, Carnegie E, Antibiotic-resistant acne: lessons from Europe. Br J Dermatol 2003;148(3):467-78
  • Coates P, Vyakrnam S, Eady EA, Prevalence of antibiotic-resistant propionibacteria on the skin of acne patients: 10-year surveillance data and snapshot distribution study. Br J Dermatol 2002;146(5):840-8
  • Simonart T, Dramaix M. Treatment of acne with topical antibiotics: lessons from clinical studies. Br J Dermatol 2005;153(2):395-403
  • Leyden JJ, McGinley KJ, Cavalieri S, Propionibacterium resistance to antibiotics in patients. J Am Acad Dermatol 1983;8:41-5
  • Barth JH, MacDonald-Hull SP, Mark J, Isotretinoin therapy for acne vulgaris: a re-evaluation of the need for measurements of plasma lipids and liver function tests. Br J Dermatol 1993;129:704-7
  • Zane LT, Leyden WA, Marqueling AL, Manos MM. A population-based analysis of laboratory abnormalities during isotretinoin therapy for acne vulgaris. Arch Dermatol 2006;142(8):1016-22
  • Guy R, Green MR, Kealey T. Modeling acne in vitro. J Invest Dermatol 1996;106:176-82
  • Burkhart CG, Burkhart CN. Expanding the microcomedone theory and acne therapeutics: Propionibacterium acnes biofilm produces biological glue that holds corneocytes together to form plug. J Am Acad Dermatol 2007;57(4):722-4
  • Zouboulis CC, Bohm M. Neuroendocrine regulation of sebocytes – a pathogenetic link between stress and acne. Exp Dermatol 2004;13(Suppl 4):31-5
  • Jugeau S, Tenaud I, Knol AC, Induction of toll-like receptors by Propionibacterium acnes. Br J Dermatol 2005;153(6):1105-13
  • Kim J, Ochoa MT, Krutzik SR, Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol 2002;169(3):1535-41
  • Muzio M, Polentarutti N, Bosisio D, Toll-like receptor family and signaling pathway. Biochem Soc Trans 2000;28(5):563-6
  • Burkhart CG, Burkhart CN, Lehmann PF. Acne: a review of immunologic and microbiologic factors. Postgrad Med J 1999;75(884):328-31
  • Jeremy AH, Holland DB, Roberts SG, Inflammatory events are involved in acne lesion initiation. J Invest Dermatol 2003;121:20-7
  • Bruggeman H, Henne A, Hoster F. The complete genome sequence of Propionibacterium acnes, a commensal of human skin. Science 2004;305:671-3
  • Burkhart CN, Burkhart CG. Genome sequence of Propionibacterium reveals immunogenic and surface-associated genes confirming existence of biofilm. Int J Dermatol 2006;45:872
  • Rojanamatin J, Choawawanich P. Treatment of inflammatory facial acne vulgaris with intense pulsed light and short contact of topical 5-aminolevulinic acid: a pilot study. Dermatol Surg 2006;32(8):991-6; discussion 996-7
  • Schaller M, Loewenstein M, Borelli C, Induction of a chemoattractive proinflammatory cytokine response after stimulation of keratinocytes with Propionibacterium acnes and coproporphyrin III. Br J Dermatol 2005;153:66-71
  • Saint-Leger D, BagueA, Cohen E, Chivot M. A possible role for squalene in the pathogenesis of acne. I. In vitro study of squalene oxidation. Br J Dermatol 1986;114:535-42
  • Evans GW, Johnson EC. Effect of iron, vitamin B-6 and picolinic acid on zinc absorption in the rat. J Nutr 1981;111(1):68-75
  • Katsambas A, Dessinioti C. New and emerging treatments in dermatology: acne. Dermatol Ther 2008;21(2):86-95
  • Gommans WM, Haisma HJ, Rots MG. Engineering zinc finger protein transcription factors: the therapeutic relevance of switching endogenous gene expression on or off at command. J Mol Biol 2005;354(3):507-19. [Epub 5 October 2005]
  • Bosco MC, Rapisarda A, Massazza S, The tryptophan catabolite picolinic acid selectively induces the chemokines macrophage inflammatory protein-1 alpha and -1 beta in macrophages. J Immunol 2000;164:3283-91
  • Cai S, Sato K, Shimizu T, Antimicrobial activity of picolinic acid against extracellular and intracellular Mycobacterium avium complex and its combined activity with clarithromycin, rifampicin and fluoroquinolones. J Antimicrob Chemother 2006;57(1):85-93. [Epub 22 November 2005]
  • Heffernan MP, Nelson MM, Anadkat MJ. A pilot study of the safety and efficacy of picolinic acid gel in the treatment of acne vulgaris. Br J Dermatol 2007;156(3):548-52
  • Draelos ZD, Carter E, Maloney JM, ; United States/Canada Dapsone Gel Study Group. Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgaris. J Am Acad Dermatol 2007;56(3):439.e1-10. [Epub 17 January 2007]
  • Zhu YI, Stiller MJ. Dapsone and sulfones in dermatology: overview and update. J Am Acad Dermatol 2001;45:420-34
  • Thiboutot D, Sharata H, Taylor S, Halder R. Pharmacokinetics of 5% dapsone topical gel demonstrates minimal systemic absorption. J Am Acad Dermatol 2005;52(Suppl):P20
  • Dreno B, Trossaert M, Boiteau HL, Litoux P. Zinc salts effects on granulocyte zinc concentration and chemotaxis in acne patients. Acta Derm Venereol 1992;72:250-2
  • Jarrousse V, Castex-Rizzi N, Khammari A, Zinc salts inhibit in vitro Toll-like receptor 2 surface expression by keratinocytes. Eur J Dermatol 2007;17(6):492-6. [Epub 19 October 2007]
  • Sainte-Marie I, Jumbou O, Tenaud I, Dreno B. Comparative study of the in vitro inflammatory activity of three nickel salts on keratinocytes. Acta Derm Venereol 1998;78:169-72
  • Verma KC, Saini AS, Dhamija SK. Oral zinc sulphate therapy in acne vulgaris: a double-blind trial. Acta Derm Venereol 1980;60(4):337-40
  • Hillström L, Pettersson L, Hellbe L, Comparison of oral treatment with zinc sulphate and placebo in acne vulgaris. Br J Dermatol 1977;97(6):681-4
  • Dreno B, Moyse D, Alirezai M, ; Acne Research and Study Group. Multicenter randomized comparative double-blind controlled clinical trial of the safety and efficacy of zinc gluconate versus minocycline hydrochloride in the treatment of inflammatory acne vulgaris. Dermatology 2001;203(2):135-40
  • Feucht CL, Allen BS, Chalker DK, Smith JGJr. Topical erythromycin with zinc in acne. A double-blind controlled study. J Am Acad Dermatol 1980;3(5):483-91
  • Dreno B, Foulc P, Reynaud A, Effect of zinc gluconate on propionibacterium acnes resistance to erythromycin in patients with inflammatory acne: in vitro and in vivo study. Eur J Dermatol 2005;15(3):152-5
  • Grosshans E, Belaïch S, Meynadier J, A comparison of the efficacy and safety of lymecycline and minocycline in patients with moderately severe acne vulgaris. Eur J Dermatol 1998;8(3):161-6
  • Galderma Australia Pty Ltd. Tetralysal (lymecycline) 300mg capsules data sheet. 1 May 2006. Available from: http://www.medsafe.govt.nz/profs/Datasheet/t/Tetralysalcap.htm
  • Carlborg B, Densert O, Lindqvist C. Tetracycline induced esophageal ulcers. A clinical and experimental study. Laryngoscope 1983;93:184-7
  • Bjellerup M, Ljunggren B. Differences in phototoxic potency should be considered when tetracyclines are prescribed during summer-time. A study on doxycycline and lymecycline in human volunteers, using an objective method for recording erythema. Br J Dermatol 1994;130:356-60
  • Bossuyt L, Bosschaert J, Richert B, Lymecycline in the treatment of acne: an efficacious, safe and cost-effective alternative to minocycline. Eur J Dermatol 2003;13(2):130-5
  • Ferner RE, Moss C. Minocycline for acne. Br Med J 1996;312:138
  • Eichenfield AH. Minocycline and autoimmunity. Curr Opin Pediatr 1999;11:447-56
  • Knowles SR, Shapiro L, Shear NH. Serious adverse reactions induced by minocycline. Arch Dermatol 1996;132:934-9
  • Dubertret L, Alirezai M, Rostain G, The use of lymecycline in the treatment of moderate to severe acne vulgaris: a comparison of the efficacy and safety of two dosing regimens. Eur J Dermatol 2003;13(1):44-8
  • Cunliffe WJ, Meynadier J, Alirezai M, Is combined oral and topical therapy better than oral therapy alone in patients with moderate to moderately severe acne vulgaris? A comparison of the efficacy and safety of lymecycline plus adapalene gel 0.1%, versus lymecycline plus gel vehicle. J Am Acad Dermatol 2003;49(Suppl 3):S218-26
  • Burkhart CN, Specht M, Neckers D. Synergistic activity of benzoyl peroxide and erythromycin. Skin Pharmacol Appl Skin Physiol 2000;13:292-6
  • Warner GT, Plosker GL. Clindamycin/benzoyl peroxide gel: a review of its use in the management of acne. Am J Clin Dermatol 2002;3(5):349-60
  • Burkhart CN, Isham N, Burkhart CG. Synergistic antimicrobial activity by combining an allylamine with benzoyl peroxide with expanded coverage against yeast and bacterial species. Br J Dermatol 2006;154:341-4
  • Leyden J, Kaidbey K, Levy SF. The combination formulation of clindamycin 1% plus benzoyl peroxide 5% versus 3 different formulations of topical clindamycin alone in the reduction of Propionibacterium acnes. Am J Clin Dermatol 2001;2:263-6
  • Eady EA, Bojar RA, Jones CE, The effect of acne treatment with a combination of benzoyl peroxide and erythromycin on skin carriage of erythromycin-resistant propionibacteria. Br J Dermatol 1996;134:107-13
  • Langner A, Chu A, Goulden V, Ambroziak M. A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide and adapalene in the treatment of mild to moderate facial acne vulgaris. Br J Dermatol 2008;158:122-9
  • Leyden J. New developments in topical antimicrobial therapy for acne. J Drugs Dermatol 2008;7(Suppl 2):s8-11
  • Burkhart CG, Burkhart CN. Antibacterial properties of soluble benzoyl peroxide. Int J Dermatol 2008;47(3):301-2
  • Tanghetti E, Kircik L, Wilson D, Dhawan S. Solubilized benzoyl peroxide versus benzoyl peroxide/clindamycin in the treatment of moderate acne. J Drugs Dermatol 2008;7(6):534-8
  • Yung A, Stables GI, Fernandez C, Microbiological effect of photodynamic therapy (PDT) in healthy volunteers: a comparative study using methyl aminolaevulinate and hexyl aminolaevulinate cream. Clin Exp Dermatol 2007;32(6):716-21
  • Kennedy JC, Pottier RH. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B 1992;14:275-92
  • Gold MH. Acne and PDT: new techniques with lasers and light sources. Lasers Med Sci 2007;22(2):67-72. [Epub 16 January 2007]
  • Hongcharu W, Taylor CR, Chang Y, Topical ALA-photodynamic therapy for the treatment of acne vulgaris. J Invest Dermatol 2000;115(2):183-92
  • Wiegell SR, Wulf HC. Photodynamic therapy of acne vulgaris using 5-aminolevulinic acid versus methyl aminolevulinate. J Am Acad Dermatol 2006;54(4):647-51
  • Nakatsuji T, Liu YT, Huang CP, Vaccination targeting a surface sialidase of P. acnes: implication for new treatment of acne vulgaris. PLoS One 2008;3(2):e1551
  • Nakatsuji T, Liu YT, Huang CP, Antibodies elicited by inactivated propionibacterium acnes-based vaccines exert protective immunity and attenuate the IL-8 production in human sebocytes: relevance to therapy for acne vulgaris. J Invest Dermatol 2008;128(10):2451-7. [Epub 8 May 2008]
  • Webster GF, Indrisano JP, Leyden JJ. Antibody titers to Propionibacterium acnes cell wall carbohydrate in nodulocystic acne patients. J Invest Dermatol 1985;84:496-500
  • Ingham E, Gowland G, Ward RM, Antibodies to P. acnes and P. acnes exocellular enzymes in the normal population at various ages and in patients with acne vulgaris. Br J Dermatol 1987;116:805-12
  • Ashbee HR, Muir SR, Cunliffe WJ, Ingham E. IgG subclasses specific to Staphylococcus epidermidis and Propionibacterium acnes in patients with acne vulgaris. Br J Dermatol 1997;136:730-3
  • Kim J. Acne vaccines: therapeutic option for the treatment of acne vulgaris? J Invest Dermatol 2008;128(10):2353-4
  • Cirioni O, Ghiselli R, Minardi D, RNAIII-inhibiting peptide affects biofilm formation in a rat model of staphylococcal ureteral stent infection. Antimicrob Agents Chemother 2007;51:4518-20
  • Cohen M, Kofonow J, Nayak JV, Biofilms in Chronic Rhinosinusitis: a review. Am J Rhinol Allergy 2009;23:255-60

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.